ClearPoint Neuro | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
ClearPoint Neuro | 8-K: Current report
ClearPoint Neuro | 8-K: ClearPoint Neuro Reports First Quarter 2024 Results
ClearPoint Neuro | DEF 14A: Definitive information statements
ClearPoint Neuro | 8-K: ClearPoint Neuro Reports Fourth Quarter and Full-Year 2023 Results
ClearPoint Neuro | 8-K: Current report
ClearPoint Neuro | 8-K: ClearPoint Neuro Reports Fourth Quarter and Full Year 2023 Preliminary Revenue Results and Guidance for Full Year 2024 Revenue
ClearPoint Neuro | S-3: Registration statement for specified transactions by certain issuers
ClearPoint Neuro | 8-K: ClearPoint Neuro Reports Third Quarter 2023 Results
ClearPoint Neuro | 8-K: ClearPoint Neuro Reports Second Quarter 2023 Results
ClearPoint Neuro | 8-K: Current report
ClearPoint Neuro | 8-K: Current report
ClearPoint Neuro | 8-K: Current report
ClearPoint Neuro | 8-K: ClearPoint Neuro Reports First Quarter 2023 Results
ClearPoint Neuro | DEF 14A: Definitive proxy statements
ClearPoint Neuro | PRE 14A: Preliminary proxy statement not related to a contested matter or merger/acquisition
ClearPoint Neuro | 8-K: Current report
ClearPoint Neuro | 8-K: ClearPoint Neuro Reports Fourth Quarter and Full-Year 2022 Results
ClearPoint Neuro | 8-K: ClearPoint Neuro Reports Fourth Quarter and Full Year 2022 Preliminary Revenue Results and Guidance for Full Year 2023 Revenue
ClearPoint Neuro | 8-K: Current report
No Data